首页> 外文期刊>International Journal of Nephrology and Renovascular Disease >Hypertension, poor glycemic control, and microalbuminuria in Cuban Americans with type 2 diabetes
【24h】

Hypertension, poor glycemic control, and microalbuminuria in Cuban Americans with type 2 diabetes

机译:古巴裔美国人患有2型糖尿病的高血压,血糖控制不佳和微量白蛋白尿

获取原文
获取外文期刊封面目录资料

摘要

Purpose: To investigate to what degree the presence of hypertension (HTN) and poor glycemic control (GC) influences the likelihood of having microalbuminuria (MAU) among Cuban Americans with type 2 diabetes (T2D).Methods: A cross-sectional study conducted in Cuban Americans (n = 179) with T2D. Participants were recruited from a randomly generated mailing list purchased from KnowledgeBase Marketing, Inc. Blood pressure (BP) was measured twice and averaged using an adult size cuff. Glycosylated hemoglobin (A1c) levels were measured from whole blood samples with the Roche Tina-quant method. First morning urine samples were collected from each participant to determine MAU by a semiquantitative assay (ImmunoDip).Results: MAU was present in 26% of Cuban Americans with T2D. A significantly higher percentage of subjects with MA had HTN (P = 0.038) and elevated A1C (P = 0.002) than those with normoalbuminuria. Logistic regression analysis showed that after controlling for covariates, subjects with poor GC were 6.76 times more likely to have MAU if they had hypertension compared with those without hypertension (P = 0.004; 95% confidence interval [CI]: 1.83, 23.05). Conclusion: The clinical significance of these findings emphasizes the early detection of MAU in this Hispanic subgroup combined with BP and good GC, which are fundamentals in preventing and treating diabetes complications and improving individuals’ renal and cardiovascular outcomes.
机译:目的:调查高血压(HTN)和血糖控制不佳(GC)的存在在多大程度上影响古巴裔美国人患有2型糖尿病(T2D)的微量白蛋白尿(MAU)的方法。 T2D的古巴裔美国人(n = 179)。参与者是从从KnowledgeBase Marketing,Inc.购买的随机生成的邮件列表中招募的。测量血压(BP)两次,并使用成人大小的袖带进行平均。糖化血红蛋白(A1c)的水平是采用Roche Tina-quant方法从全血样本中测得的。每天早晨从每个参与者收集尿液样品,以通过半定量测定法(ImmunoDip)测定MAU。结果:26%的美国古巴T2D患者中存在MAU。与正常白蛋白尿患者相比,MA患者的HTN(P = 0.038)和A1C升高(P = 0.002)显着更高。 Logistic回归分析表明,在控制了协变量之后,GC较差的受试者与未高血压的受试者相比,发生高血压的受试者发生MAU的可能性高6.76倍(P = 0.004; 95%置信区间[CI]:1.83,23.05)。结论:这些发现的临床意义强调了在该西班牙裔亚组中结合BP和良好的GC早期检测MAU,这是预防和治疗糖尿病并发症以及改善个人的肾脏和心血管预后的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号